Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04505618 · ClinicalTrials.gov registry record · NA
Optical Coherence Tomography Angiography in Subjects With Retinal Vascular Disease
A NA study of Diabetic Retinopathy and Retinal Vein Occlusion, sponsored by Johns Hopkins University.
- Recruiting
- Registry status
- NA
- Development phase
- 1,050
- Enrollment target
- 1
- Study location
NCT04505618 is a NA study of Diabetic Retinopathy and Retinal Vein Occlusion that is actively recruiting participants, run by Johns Hopkins University. The registered enrollment target is 1,050 participants, below the 1,658-participant average among 57 other Diabetic Retinopathy trials with a reported enrollment target (37% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04505618, a NA study of Diabetic Retinopathy and Retinal Vein Occlusion, is actively recruiting participants, sponsored by Johns Hopkins University.
- RECRUITING
- Registry status
- NA
- Development phase
- 1,050 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will perform a prospective, longitudinal analysis of clinical and imaging findings from normal controls and subjects with retinal vascular disease to better define the diagnostic imaging criteria that signify change in disease stage. This includes disease progression in early stages of disease or disease regression with appropriate standard-of-care treatment.
Conditions Studied
Interventions
- DEVICE Swept-Source (SS) OCT Angiography
- DEVICE Spectral-Domain (SD) OCT Angiography
- DEVICE Fundus Imaging
- DEVICE Axial Length Measurement Device
Study Locations (1)
Maryland
- Wilmer Eye Institute - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,050 participants |
| Start Date | 2019-10-01 |
| Est. Completion | 2026-09-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04505618
The ClinicalTrials.gov registry entry for NCT04505618 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 1,050 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,658-participant average among 57 other Diabetic Retinopathy trials with a reported enrollment target (37% lower). The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Diabetic Retinopathy appearing as the primary indexed condition, and to 4 interventions - of which Swept-Source (SS) OCT Angiography is the first listed.
NCT04505618 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT04505618 about?
NCT04505618 is a clinical study titled "Optical Coherence Tomography Angiography in Subjects With Retinal Vascular Disease". This study will perform a prospective, longitudinal analysis of clinical and imaging findings from normal controls and subjects with retinal vascular disease to better define the diagnostic imaging criteria that signify change in disease stage. This includes disease progression in early stages of di...
What is the current status of trial NCT04505618?
This trial is currently recruiting. It is a NA study. The enrollment target is 1,050 participants. The study started on 2019-10-01. Estimated completion is 2026-09-01.
What conditions does trial NCT04505618 study?
This clinical trial studies the following conditions: Diabetic Retinopathy, Retinal Vein Occlusion, Hypertension,Essential, Retinal Vascular Disorder.
What interventions are being tested in trial NCT04505618?
The interventions under investigation include: Swept-Source (SS) OCT Angiography (DEVICE), Spectral-Domain (SD) OCT Angiography (DEVICE), Fundus Imaging (DEVICE), Axial Length Measurement Device (DEVICE).
Who is sponsoring clinical trial NCT04505618?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04505618 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetic Retinopathy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Village-Integrated Eye Worker Trial II
RECRUITING · NA
-
Video-based Patient Education Intervention for Diabetic Eye Screening in Latinx Communities
RECRUITING · NA
-
Clinical Applications of Advanced Ophthalmic Imaging
RECRUITING · NA
-
Implementation of Teleophthalmology in Urban Health Systems Study
ACTIVE NOT RECRUITING · NA
-
Manhattan Vision Screening and Follow-Up Study (NYC-SIGHT)
ACTIVE NOT RECRUITING · NA
-
Circadian Amplification in Diabetic Retinopathy
COMPLETED · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.